PROJECT

Projects

Environmental & Social Review Summary

Project Number

49897

Company Name

Shandong Weigao Group Medical Polymer Co., Ltd.

Date ESRS Disclosed

Jan 16, 2025

Country

East Asia and Pacific Region

Region

East Asia and the Pacific

Last Updated Date

Apr 30, 2025

Environmental Category

B - Limited

Status

Active

Previous Events

Approved : Dec 3, 2024
Signed : Dec 6, 2024
Invested : Apr 24, 2025

Sector

other

Industry

other

Department

CM4S2 - Regional Industry - MAS Asia & Pac/MAS Services, EAP

Project Description

Shandong Weigao Group Medical Polymer Company Limited, (“Weigao” or the “Company” - http://en.weigaogroup.com/index.php/home/category/index/sc_id/index.php) listed on the Hong Kong Stock Exchange, is a leading domestic manufacturer of single-use medical devices in China.

Weigao is organized into six operating divisions: (i) medical device products (infusion set, syringes, medical needles, pre-filling syringes), (ii) orthopedic products, (iii) interventional products; (iv) pharma packaging products; (v) blood management products; and (vi) others. Weigao’s manufacturing operations are situated mainly in Weihai, Shandong Province. Weigao also has a number of other subsidiaries in the group, viz.: Weigao Medical Device; Weigao Orthopedic and Argon Medical (in United States).

The proposed financing package will consist of: (i) an A loan of up to US$250 million; and (ii) debt mobilization of up to US$100 million equivalent from other development finance institution (“DFI”) in the form of a straight senior loan, as well as potential core mobilization from other financial institutions. The proposed financing is to support Weigao: (i) to upgrade its manufacturing facilities in China, including up to US$150 million of green capital expenditure for improving resource efficiency in production; (ii) to support its Southeast Asia expansion; and (iii) for research and development (R&D) of new products to further diversify its product portfolio (the “Project”).

IFC supported previous projects with the Company as follows:

“Weigao GreenBond” in 2019 (https://disclosures.ifc.org/project-detail/ESRS/43238/weigao-greenbond) “Weigao II” in 2014 (https://disclosures.ifc.org/project-detail/ESRS/34313/weigao-ii ); and “Weigao” in 2006 (https://disclosures.ifc.org/project-detail/ESRS/25099/weigao). Ongoing supervision of the existing investments indicates the Company’s environmental and social performance is generally satisfactory.

E & S Project Categorization and Applicable Standard

Environmental and Social Mitigation Measures

Stakeholder Engagement

Broad Community Support

Environmental & Social Action Plan